Landscapes / Companies
Wuhan Createrna Science and Technology Co., Ltd not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 in Phase 3
Drugs
2
in active trials · 4 in all
Trials
6 active
14 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 3 | 30 Dec 2026Phase 2/3 trial completes | |||
| Next date | 30 Dec 2026 · Phase 2/3 trial completes | ||||
| Also tested for | Paroxysmal Nocturnal Hemoglobinuria (PNH), IgA Nephropathy (IgAN) and 2 more | ||||
| Open drug page | |||||
— |
Phase 3 | — | |||
| Also tested for | Essential Hypertension | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021